Gardner Lewis Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-21,216
| Closed | -$4.56M | – | 89 |
|
|
2021
Q1 | $4.56M | Sell |
21,216
-10,820
| -34% | -$2.33M | 0.82% | 47 |
|
|
2020
Q4 | $7.57M | Hold |
32,036
| – | – | 1.76% | 21 |
|
|
2020
Q3 | $8.72M | Sell |
32,036
-175
| -0.5% | -$47.6K | 1.58% | 22 |
|
|
2020
Q2 | $9.35M | Sell |
32,211
-1,213
| -4% | -$352K | 1.73% | 19 |
|
|
2020
Q1 | $7.95M | Sell |
33,424
-4,092
| -11% | -$974K | 1.32% | 21 |
|
|
2019
Q4 | $8.21M | Sell |
37,516
-6,044
| -14% | -$1.32M | 1.12% | 22 |
|
|
2019
Q3 | $7.38M | Buy |
43,560
+9,633
| +28% | +$1.63M | 1.11% | 24 |
|
|
2019
Q2 | $6.22M | Sell |
33,927
-580
| -2% | -$106K | 0.76% | 33 |
|
|
2019
Q1 | $6.35M | Buy |
34,507
+1,870
| +6% | +$344K | 0.79% | 28 |
|
|
2018
Q4 | $5.41M | Buy |
32,637
+3,583
| +12% | +$594K | 0.49% | 33 |
|
|
2018
Q3 | $5.6M | Sell |
29,054
-150
| -0.5% | -$28.9K | 0.43% | 38 |
|
|
2018
Q2 | $4.96M | Buy |
29,204
+2,520
| +9% | +$428K | 0.38% | 42 |
|
|
2018
Q1 | $4.35M | Buy |
26,684
+7,287
| +38% | +$1.19M | 0.34% | 48 |
|
|
2017
Q4 | $2.91M | Buy |
+19,397
| New | +$2.91M | 0.25% | 58 |
|
|
2016
Q2 | – | Sell |
-28,445
| Closed | -$2.26M | – | 121 |
|
|
2016
Q1 | $2.26M | Sell |
28,445
-725
| -2% | -$57.6K | 0.44% | 47 |
|
|
2015
Q4 | $3.67M | Buy |
29,170
+7,240
| +33% | +$911K | 0.58% | 47 |
|
|
2015
Q3 | $2.28M | Buy |
+21,930
| New | +$2.28M | 0.32% | 64 |
|